Potential of proton therapy to reduce acute hematologic toxicity in concurrent chemoradiation therapy for esophageal cancer

HIGHLIGHTS

• who: Samantha Warren PhD from the Laboratories, University of Oxford, Oxford, United Kingdom have published the Article: Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer, in the Journal: (JOURNAL)
• what: The results of this study have shown that proton can licenses/by/4.0/).
• how: The dose distribution data were compared quantitatively for all patients for each technique (Fig 2 Table E1 available online at www.redjournal.org).
• future: The conclusions from this study might not be applicable when using different beam geometries . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.